Stryker Corporation vs Tidewater Inc — how do they compare? Stryker Corporation trades at $277.3 (market cap $105.63B), while Tidewater Inc trades at $92.78 (market cap $4.63B). The key difference: Stryker Corporation is far larger — about 22.8× Tidewater Inc's market cap, and Stryker Corporation pays a 1.28% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals.
| SYK | TDW | |
|---|---|---|
Market Cap | $105.63B | $4.63B |
Sector | Technology | Utilities |
52-Week High | $388.79 | $100.61 |
52-Week Low | $275.39 | $47.29 |
Enterprise Value | $117.10B | $4.67B |
Dividend Yield | 1.28% | — |
Signals from Pluang's Aura AI — not financial advice
Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.
Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.
Tidewater (TDW) trades at $92.00, down 2.4% on the day, with a bullish technical signal supported by moving averages and a consensus price target of $105.50. Recent Q2 2026 earnings of $0.43 per share beat expectations, while the company completed the Wilson Sons Ultratug acquisition in August 2026, signaling growth in offshore energy services. Financial health is solid with a net income margin of 18.34% and strong cash flow from operations of $379.11 million in 2025.
The outlook is cautiously optimistic, with upside potential from analyst targets and operational strength, but risks include earnings volatility, as seen in Q1 and Q2 2026 misses, and exposure to energy market fluctuations. Investor sentiment is mixed, with a majority hold rating from analysts, suggesting a balanced view amid acquisition integration and competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →